HIF1A and breast cancer: According to Mangraviti and his colleagues, ACF can inhibit transcriptional activity of HIF-1α not only in brain cancer but also in cholangiocarcinoma (SK-ChA-1), ovarian (A2780), or breast cancer (MCF-7) cell lines [160].